← Back to guidelines
Emergency Medicine18 papers

Myelopathy after venomous injury

Last edited: 4/15/2026

Overview

Myelopathy following venomous injuries typically results from neurotoxic venom affecting the spinal cord, potentially leading to motor deficits, sensory disturbances, and autonomic dysfunction. Specific venom types, such as those from rattlesnakes, can cause severe complications including thrombocytopenia 1.

Diagnosis

  • Clinical presentation includes progressive motor weakness, sensory changes, and potential autonomic dysfunction.
  • Laboratory tests: Assess for thrombocytopenia and coagulopathy, especially relevant in cases involving rattlesnake venom 1.
  • Imaging: MRI may reveal spinal cord edema or compression [Not specified in abstracts].
  • Grading systems: Utilize scales like the American Spinal Injury Association (ASIA) Impairment Scale for severity assessment [Not specified in abstracts].
  • Management

  • First-line treatments:
  • - Venom antivenom administration as soon as possible post-bite [Not specified in abstracts]. - Supportive care including monitoring for and managing coagulopathy and thrombocytopenia 1.
  • Adjunctive treatments:
  • - High voltage direct current (HVDC) therapy has shown efficacy in arresting tissue damage in venom-related injuries, though primarily noted in spider bites 2. - Pain management and immobilization to prevent further spinal cord injury [Not specified in abstracts].

    Special Populations

  • Pregnancy: Specific management guidelines not provided in the abstracts [Not specified in abstracts].
  • Pediatrics: No specific data provided regarding pediatric cases [Not specified in abstracts].
  • Elderly: Increased susceptibility to complications due to comorbid conditions; supportive care tailored to individual health status is crucial [Not specified in abstracts].
  • Comorbidities: Patients with pre-existing coagulopathies or thrombocytopenia may require more intensive monitoring and treatment 1.
  • Key Recommendations

  • Administer antivenom promptly in cases of rattlesnake envenomation to mitigate severe systemic effects including thrombocytopenia (Evidence: Expert opinion 1).
  • Monitor for and manage coagulopathy and thrombocytopenia closely, especially in patients with rattlesnake envenomation (Evidence: Expert opinion 1).
  • Consider high voltage direct current therapy for arresting tissue damage in severe venom-related injuries, though primarily validated in spider bites (Evidence: Weak 2).
  • References

    1 Christiansen J, Fieselmann J. Massasauga rattlesnake bites in Iowa. Iowa medicine : journal of the Iowa Medical Society 1993. link 2 Osborn CD. Treatment of venomous bite by high voltage direct current. The Journal of the Oklahoma State Medical Association 1990. link

    Original source

    1. [1]
      Massasauga rattlesnake bites in Iowa.Christiansen J, Fieselmann J Iowa medicine : journal of the Iowa Medical Society (1993)
    2. [2]
      Treatment of venomous bite by high voltage direct current.Osborn CD The Journal of the Oklahoma State Medical Association (1990)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG